Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Dong Kee Jang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6642-6635; OpenAlex author ID A5077022498. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Sex-specific prognostic value of triceps skinfold thickness and albumin in pancreatic cancer. Co-author DOI 10.1016/j.isci.2026.115290↗
  2. Effectiveness and cost analysis of liposomal irinotecan in patients with pancreatic adenocarcinoma: a multicenter real-world study. Co-author DOI 10.1177/17588359251370492↗
  3. Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer. Co-author DOI 10.3389/fonc.2024.1510016↗
  4. The Trends and Outcomes of Initial Palliative Chemotherapy in Patients with Pancreatic Cancer in Korea Based on National Health Insurance Service Data. Co-author DOI 10.3390/jcm13113229↗
  5. Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment. Co-author DOI 10.1186/s12885-019-6193-0↗
  6. Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy. Co-author DOI 10.5009/gnl16307↗
  7. Early decrement of serum carbohydrate antigen 19-9 predicts favorable outcome in advanced pancreatic cancer. Co-author DOI 10.1111/jgh.13075↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Young Ae Kim · 3 shared papers, 2024–2025 · strength 0.68
  2. Jin‐Hyeok Hwang · 3 shared papers, 2024–2025 · strength 0.68
  3. Yoon Suk Lee · 3 shared papers, 2024–2025 · strength 0.68
  4. Jung Won Chun · 3 shared papers, 2024–2025 · strength 0.68
  5. Sang Myung Woo · 3 shared papers, 2024–2025 · strength 0.68
  6. Jong-Chan Lee · 2 shared papers, 2024–2025 · strength 0.46
  7. Hyemin Kim · 1 shared paper, 2026 · strength 0.28
  8. Young Hoon Cho · 1 shared paper, 2026 · strength 0.28
  9. Joo Kyung Park · 1 shared paper, 2026 · strength 0.28
  10. Woo Jin Lee · 1 shared paper, 2025 · strength 0.25
  11. Ji Kon Ryu · 3 shared papers, 2016–2019 · strength 0.24
  12. Jong-chan Lee · 1 shared paper, 2024 · strength 0.22
  13. Yong‐Tae Kim · 2 shared papers, 2016–2019 · strength 0.16
  14. Kwang Hyun Chung · 2 shared papers, 2016–2017 · strength 0.15
  15. Sang Hyub Lee · 2 shared papers, 2016–2017 · strength 0.15
  16. Woo Hyun Paik · 1 shared paper, 2019 · strength 0.09
  17. Min Su You · 1 shared paper, 2019 · strength 0.09
  18. Jun Kyu Lee · 1 shared paper, 2019 · strength 0.09
  19. Jin Ho Choi MD · 1 shared paper, 2019 · strength 0.09
  20. Jin‐Young Jang · 1 shared paper, 2019 · strength 0.09
  21. Sun‐Whe Kim · 1 shared paper, 2019 · strength 0.09
  22. Wooil Kwon · 1 shared paper, 2019 · strength 0.09
  23. Jae Woo Lee · 1 shared paper, 2017 · strength 0.08
  24. Yong‐Tae Kim · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.